Form 4: Clarus Corp. Director Nicolas Sokolow Granted 20,000 Stock Options

Clarus Corp. Director Nicolas Sokolow was granted 20,000 stock options with a $3.21 exercise price, vesting quarterly through March 2026.

Summary

• Nicolas Sokolow, a Director of Clarus Corp. (CLAR), was granted 20,000 stock options on May 29, 2025.
• The stock options have an exercise price of $3.21 per share.
• These options were granted under the Issuer's Amended and Restated 2015 Stock Incentive Plan.
• The options will vest in four equal tranches of 5,000 shares each.
• Vesting dates are scheduled for June 30, 2025, September 30, 2025, December 31, 2025, and March 31, 2026.
• The expiration date for these stock options is May 29, 2035.
• Following this transaction, Nicolas Sokolow beneficially owns 20,000 derivative securities (stock options) directly.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive as the grant of stock options aligns the director's interests with shareholders, which is generally viewed favorably. However, it is a routine compensation disclosure and not indicative of significant operational or financial news.

Positives

• The grant of stock options to a director aligns management's interests with those of shareholders, incentivizing long-term company performance.
• The options are granted under an existing and approved stock incentive plan, indicating a structured approach to executive compensation.

Future Outlook

The vesting schedule of the stock options indicates a future potential for the director to exercise these options, contingent on the company's stock performance relative to the exercise price and the director's continued service.

Industry Context

The grant of stock options is a common form of executive and director compensation across various industries, designed to incentivize long-term performance and align the interests of key personnel with those of shareholders.

Comparison to Industry Standards

• Granting stock options as part of director compensation is a standard practice in publicly traded companies, aligning with typical corporate governance frameworks.
• The specific size of the grant (20,000 options) and the exercise price ($3.21) would need to be compared against peer companies of similar market capitalization and industry to assess if it is within typical ranges, though this document does not provide such comparative data.

Corporate Governance

Related Party Transactions

• The grant of stock options to Nicolas Sokolow, a director of Clarus Corp., constitutes a related party transaction as it involves compensation to a member of the company's board.

Stakeholder Impact

• Shareholders: The grant aims to align the director's financial interests with shareholder value creation, potentially leading to better long-term performance.
• Employees: No direct impact on general employees is indicated by this specific filing.

Next Steps

• The stock options will vest in four quarterly installments, with the first vesting on June 30, 2025.
• Nicolas Sokolow may choose to exercise the vested options at any time before the expiration date of May 29, 2035, subject to company policy and market conditions.

Key Dates

Keywords

Clarus Corp, CLAR, Stock Options, Form 4, Insider Transaction, Executive Compensation, Director Compensation, Equity Grant, Nicolas Sokolow